Nanoscale drug formulations for the treatment of Alzheimer's disease progression
RSC Advances · 2025 · 15 (6) · 4031-4078
DOI: 10.1039/d4ra08128e ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2025. Verfasst von Liqin Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics of Neurology Nursing, West China School of Nursing, West China Second University Hospital, Sichuan University Chengdu 610000…. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 268 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: China Postdoctoral Science Foundation, Central University Basic Research Fund of China.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a devastating neurodegenerative disorder with no effective disease-modifying treatments.
Autor:innen und Institutionen
- Department of Pediatrics of Neurology Nursing, West China School of Nursing, West China Second University Hospital, Sichuan University Chengdu 610000 China 2398547353@qq.com.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education Chengdu 610000 China.
- State Key Laboratory of Biotherapy, West China Hospital, Sichuan University Chengdu 610000 China bin.du@scu.edu.cn.
- Department of Pediatrics, West China Second University Hospital, Sichuan University Chengdu 610000 China heyang1235@126.com.
ORCID-Profile: Bin Du
Förderung
- China Postdoctoral Science Foundation
- Central University Basic Research Fund of China
Zitieren
APA
Liu, L., He, H., Du, B., & He, Y. (2025). Nanoscale drug formulations for the treatment of Alzheimer's disease progression. RSC Advances, 15(6), 4031-4078. https://doi.org/10.1039/d4ra08128e
Vancouver
Liu L, He H, Du B, He Y. Nanoscale drug formulations for the treatment of Alzheimer's disease progression. RSC Advances. 2025;15(6):4031-4078. doi:10.1039/d4ra08128e
BibTeX
@article{Liu2025,
author = {Liu, Liqin and He, Haini and Du, Bin and He, Yang},
title = {Nanoscale drug formulations for the treatment of Alzheimer's disease progression},
journal = {RSC Advances},
year = {2025},
volume = {15},
number = {6},
pages = {4031--4078},
doi = {10.1039/d4ra08128e}
}
EUVIMED